NasdaqCM - Delayed Quote USD
Outlook Therapeutics, Inc. (OTLK)
1.9000
0.0000
(0.00%)
At close: June 9 at 4:00:00 PM EDT
1.9300
+0.03
+(1.58%)
After hours: June 9 at 6:22:23 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| EVANSON JEFF Officer | Purchase | Mar 7, 2024 | 808,459 |
| HADDADIN YEZAN MUNTHER Director | Purchase | Mar 28, 2024 | 5,048 |
| KENYON LAWRENCE A. Chief Financial Officer | Purchase | Sep 26, 2024 | 5,946 |
| SUKHTIAN GHIATH M Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | May 27, 2025 | -- |
| SYNTONE VENTURES, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 15, 2024 | 1,705,440 |
Related Tickers
KALV KalVista Pharmaceuticals, Inc.
14.76
+2.75%
RIGL Rigel Pharmaceuticals, Inc.
21.85
+1.68%
PYPD PolyPid Ltd.
3.3600
+2.75%
UNCY Unicycive Therapeutics, Inc.
0.9000
+19.30%
VTGN Vistagen Therapeutics, Inc.
2.3400
-0.85%
NUVB Nuvation Bio Inc.
2.5100
+1.21%
URGN UroGen Pharma Ltd.
7.02
-4.75%
FBIO Fortress Biotech, Inc.
2.1300
+6.50%
AMLX Amylyx Pharmaceuticals, Inc.
5.44
+2.06%
NMRA Neumora Therapeutics, Inc.
1.0900
+6.86%